David Charles Baker - 23 Jan 2025 Form 4 Insider Report for GRI Bio, Inc. (GRI)

Role
Director
Signature
/s/ Leanne Kelly, Attorney-in-Fact
Issuer symbol
GRI
Transactions as of
23 Jan 2025
Net transactions value
+$20,775
Form type
4
Filing time
24 Jan 2025, 17:57:45 UTC
Previous filing
14 Aug 2023
Next filing
14 Aug 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRI Stock Option (Right to Buy) Award $20,775 +30,297 $0.6857 30,297 23 Jan 2025 Common Stock 30,297 $0.6857 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.